Pitch-HF: Phosphodiesterase Type 5 Inhibition with Tadalafil Changes Outcomes in Heart Failure

Project: Research project

Project Details


To evaluate the safety, effectiveness, and effects on functional capacity/ quality of life of tadalafil, compared to placebo
Effective start/end date11/18/132/10/14


  • New England Research Institutes, Inc. (Sub under U01 HL105463 // Sub under U01 HL105463)
  • National Heart, Lung, and Blood Institute (Sub under U01 HL105463 // Sub under U01 HL105463)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.